 | • レポートコード：B-GIR08C1005 • 出版社/出版日：GlobalInfoResearch / 2019年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、136ページ • 納品方法：Eメール • 産業分類：Pharma & Healthcare |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、癌バイオ医薬品の世界市場について調べ、まとめました。種類別セグメントは、生物製剤、バイオシミラー等、用途別セグメントは、等に区分しました。癌バイオ医薬品の世界市場概観、企業動向、企業別癌バイオ医薬品シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・癌バイオ医薬品の市場概観 ・癌バイオ医薬品の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・癌バイオ医薬品の企業別販売動向、市場シェア、市場集中度、競争動向 ・癌バイオ医薬品の世界市場規模 ・癌バイオ医薬品の北米市場分析（アメリカ、カナダ、メキシコ等） ・癌バイオ医薬品のアメリカ市場規模推移 ・癌バイオ医薬品のカナダ市場規模推移 ・癌バイオ医薬品のメキシコ市場規模推移 ・癌バイオ医薬品のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・癌バイオ医薬品のドイツ市場規模推移 ・癌バイオ医薬品のイギリス市場規模推移 ・癌バイオ医薬品のロシア市場規模推移 ・癌バイオ医薬品のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・癌バイオ医薬品の日本市場規模推移 ・癌バイオ医薬品の中国市場規模推移 ・癌バイオ医薬品の韓国市場規模推移 ・癌バイオ医薬品のインド市場規模推移 ・癌バイオ医薬品の東南アジア市場規模推移 ・癌バイオ医薬品の南米市場分析（ブラジル、アルゼンチン等） ・癌バイオ医薬品の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・癌バイオ医薬品の種類別分析/販売量、売上、市場シェア（生物製剤、バイオシミラー） ・癌バイオ医薬品の用途別分析/市場規模（） ・癌バイオ医薬品の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・癌バイオ医薬品の販売チャネル・代理店・貿易業者・ディーラー分析 |
Biopharmaceutical, also known as a biologic (al) medical product, biological, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semi synthesized from biological sources. Cancer is a complex invasive genetic disease that causes significant mortality rate worldwide. Cancer drugs are the primary concern in terms of drug development trends.
Scope of the Report:
The global Cancer Biopharmaceuticals market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Cancer Biopharmaceuticals.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Cancer Biopharmaceuticals market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Cancer Biopharmaceuticals market by product type and applications/end industries.
Market Segment by Companies, this report covers
Sanofi
Johnson & Johnson
Pfizer
Novartis
Merck
GlaxoSmithKline
Eli Lilly
Agios Pharmaceuticals
Bristol-Myers Squibb
AstraZeneca
Mylan
LEO Pharma
Boehringer Ingelheim
Alexion Pharmaceuticals
Elusys Therapeutics
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Biologics
Biosimilars
Market Segment by Applications, can be divided into
Liquid Cancers
Solid Cancers
Table of Contents
1 Cancer Biopharmaceuticals Market Overview
1.1 Product Overview and Scope of Cancer Biopharmaceuticals
1.2 Classification of Cancer Biopharmaceuticals by Types
1.2.1 Global Cancer Biopharmaceuticals Revenue Comparison by Types (2019-2024)
1.2.2 Global Cancer Biopharmaceuticals Revenue Market Share by Types in 2018
1.2.3 Biologics
1.2.4 Biosimilars
1.3 Global Cancer Biopharmaceuticals Market by Application
1.3.1 Global Cancer Biopharmaceuticals Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Liquid Cancers
1.3.3 Solid Cancers
1.4 Global Cancer Biopharmaceuticals Market by Regions
1.4.1 Global Cancer Biopharmaceuticals Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Cancer Biopharmaceuticals Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Cancer Biopharmaceuticals Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Cancer Biopharmaceuticals Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Cancer Biopharmaceuticals Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Cancer Biopharmaceuticals Status and Prospect (2014-2024)
1.5 Global Market Size of Cancer Biopharmaceuticals (2014-2024)
2 Manufacturers Profiles
2.1 Sanofi
2.1.1 Business Overview
2.1.2 Cancer Biopharmaceuticals Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Sanofi Cancer Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
2.2 Johnson & Johnson
2.2.1 Business Overview
2.2.2 Cancer Biopharmaceuticals Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Johnson & Johnson Cancer Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
2.3 Pfizer
2.3.1 Business Overview
2.3.2 Cancer Biopharmaceuticals Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Pfizer Cancer Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
2.4 Novartis
2.4.1 Business Overview
2.4.2 Cancer Biopharmaceuticals Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Novartis Cancer Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
2.5 Merck
2.5.1 Business Overview
2.5.2 Cancer Biopharmaceuticals Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Merck Cancer Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
2.6 GlaxoSmithKline
2.6.1 Business Overview
2.6.2 Cancer Biopharmaceuticals Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 GlaxoSmithKline Cancer Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
2.7 Eli Lilly
2.7.1 Business Overview
2.7.2 Cancer Biopharmaceuticals Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Eli Lilly Cancer Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
2.8 Agios Pharmaceuticals
2.8.1 Business Overview
2.8.2 Cancer Biopharmaceuticals Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Agios Pharmaceuticals Cancer Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
2.9 Bristol-Myers Squibb
2.9.1 Business Overview
2.9.2 Cancer Biopharmaceuticals Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Bristol-Myers Squibb Cancer Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
2.10 AstraZeneca
2.10.1 Business Overview
2.10.2 Cancer Biopharmaceuticals Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 AstraZeneca Cancer Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
2.11 Mylan
2.11.1 Business Overview
2.11.2 Cancer Biopharmaceuticals Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Mylan Cancer Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
2.12 LEO Pharma
2.12.1 Business Overview
2.12.2 Cancer Biopharmaceuticals Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 LEO Pharma Cancer Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
2.13 Boehringer Ingelheim
2.13.1 Business Overview
2.13.2 Cancer Biopharmaceuticals Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Boehringer Ingelheim Cancer Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
2.14 Alexion Pharmaceuticals
2.14.1 Business Overview
2.14.2 Cancer Biopharmaceuticals Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Alexion Pharmaceuticals Cancer Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
2.15 Elusys Therapeutics
2.15.1 Business Overview
2.15.2 Cancer Biopharmaceuticals Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Elusys Therapeutics Cancer Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
3 Global Cancer Biopharmaceuticals Market Competition, by Players
3.1 Global Cancer Biopharmaceuticals Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Cancer Biopharmaceuticals Players Market Share
3.2.2 Top 10 Cancer Biopharmaceuticals Players Market Share
3.3 Market Competition Trend
4 Global Cancer Biopharmaceuticals Market Size by Regions
4.1 Global Cancer Biopharmaceuticals Revenue and Market Share by Regions
4.2 North America Cancer Biopharmaceuticals Revenue and Growth Rate (2014-2019)
4.3 Europe Cancer Biopharmaceuticals Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Cancer Biopharmaceuticals Revenue and Growth Rate (2014-2019)
4.5 South America Cancer Biopharmaceuticals Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Cancer Biopharmaceuticals Revenue and Growth Rate (2014-2019)
5 North America Cancer Biopharmaceuticals Revenue by Countries
5.1 North America Cancer Biopharmaceuticals Revenue by Countries (2014-2019)
5.2 USA Cancer Biopharmaceuticals Revenue and Growth Rate (2014-2019)
5.3 Canada Cancer Biopharmaceuticals Revenue and Growth Rate (2014-2019)
5.4 Mexico Cancer Biopharmaceuticals Revenue and Growth Rate (2014-2019)
6 Europe Cancer Biopharmaceuticals Revenue by Countries
6.1 Europe Cancer Biopharmaceuticals Revenue by Countries (2014-2019)
6.2 Germany Cancer Biopharmaceuticals Revenue and Growth Rate (2014-2019)
6.3 UK Cancer Biopharmaceuticals Revenue and Growth Rate (2014-2019)
6.4 France Cancer Biopharmaceuticals Revenue and Growth Rate (2014-2019)
6.5 Russia Cancer Biopharmaceuticals Revenue and Growth Rate (2014-2019)
6.6 Italy Cancer Biopharmaceuticals Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Cancer Biopharmaceuticals Revenue by Countries
7.1 Asia-Pacific Cancer Biopharmaceuticals Revenue by Countries (2014-2019)
7.2 China Cancer Biopharmaceuticals Revenue and Growth Rate (2014-2019)
7.3 Japan Cancer Biopharmaceuticals Revenue and Growth Rate (2014-2019)
7.4 Korea Cancer Biopharmaceuticals Revenue and Growth Rate (2014-2019)
7.5 India Cancer Biopharmaceuticals Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Cancer Biopharmaceuticals Revenue and Growth Rate (2014-2019)
8 South America Cancer Biopharmaceuticals Revenue by Countries
8.1 South America Cancer Biopharmaceuticals Revenue by Countries (2014-2019)
8.2 Brazil Cancer Biopharmaceuticals Revenue and Growth Rate (2014-2019)
8.3 Argentina Cancer Biopharmaceuticals Revenue and Growth Rate (2014-2019)
8.4 Colombia Cancer Biopharmaceuticals Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Cancer Biopharmaceuticals by Countries
9.1 Middle East and Africa Cancer Biopharmaceuticals Revenue by Countries (2014-2019)
9.2 Saudi Arabia Cancer Biopharmaceuticals Revenue and Growth Rate (2014-2019)
9.3 UAE Cancer Biopharmaceuticals Revenue and Growth Rate (2014-2019)
9.4 Egypt Cancer Biopharmaceuticals Revenue and Growth Rate (2014-2019)
9.5 Nigeria Cancer Biopharmaceuticals Revenue and Growth Rate (2014-2019)
9.6 South Africa Cancer Biopharmaceuticals Revenue and Growth Rate (2014-2019)
10 Global Cancer Biopharmaceuticals Market Segment by Type
10.1 Global Cancer Biopharmaceuticals Revenue and Market Share by Type (2014-2019)
10.2 Global Cancer Biopharmaceuticals Market Forecast by Type (2019-2024)
10.3 Biologics Revenue Growth Rate (2014-2024)
10.4 Biosimilars Revenue Growth Rate (2014-2024)
11 Global Cancer Biopharmaceuticals Market Segment by Application
11.1 Global Cancer Biopharmaceuticals Revenue Market Share by Application (2014-2019)
11.2 Cancer Biopharmaceuticals Market Forecast by Application (2019-2024)
11.3 Liquid Cancers Revenue Growth (2014-2019)
11.4 Solid Cancers Revenue Growth (2014-2019)
12 Global Cancer Biopharmaceuticals Market Size Forecast (2019-2024)
12.1 Global Cancer Biopharmaceuticals Market Size Forecast (2019-2024)
12.2 Global Cancer Biopharmaceuticals Market Forecast by Regions (2019-2024)
12.3 North America Cancer Biopharmaceuticals Revenue Market Forecast (2019-2024)
12.4 Europe Cancer Biopharmaceuticals Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Cancer Biopharmaceuticals Revenue Market Forecast (2019-2024)
12.6 South America Cancer Biopharmaceuticals Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Cancer Biopharmaceuticals Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure Cancer Biopharmaceuticals Picture
Table Product Specifications of Cancer Biopharmaceuticals
Table Global Cancer Biopharmaceuticals and Revenue (Million USD) Market Split by Product Type
Figure Global Cancer Biopharmaceuticals Revenue Market Share by Types in 2018
Figure Biologics Picture
Figure Biosimilars Picture
Table Global Cancer Biopharmaceuticals Revenue (Million USD) by Application (2014-2024)
Figure Cancer Biopharmaceuticals Revenue Market Share by Applications in 2018
Figure Liquid Cancers Picture
Figure Solid Cancers Picture
Table Global Market Cancer Biopharmaceuticals Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Cancer Biopharmaceuticals Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Cancer Biopharmaceuticals Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Cancer Biopharmaceuticals Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Cancer Biopharmaceuticals Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Cancer Biopharmaceuticals Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Cancer Biopharmaceuticals Revenue (Million USD) and Growth Rate (2014-2024)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Cancer Biopharmaceuticals Type and Applications
Table Sanofi Cancer Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Cancer Biopharmaceuticals Type and Applications
Table Johnson & Johnson Cancer Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Cancer Biopharmaceuticals Type and Applications
Table Pfizer Cancer Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Cancer Biopharmaceuticals Type and Applications
Table Novartis Cancer Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Cancer Biopharmaceuticals Type and Applications
Table Merck Cancer Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table GlaxoSmithKline Cancer Biopharmaceuticals Type and Applications
Table GlaxoSmithKline Cancer Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
Table Eli Lilly Basic Information, Manufacturing Base and Competitors
Table Eli Lilly Cancer Biopharmaceuticals Type and Applications
Table Eli Lilly Cancer Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
Table Agios Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Agios Pharmaceuticals Cancer Biopharmaceuticals Type and Applications
Table Agios Pharmaceuticals Cancer Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table Bristol-Myers Squibb Cancer Biopharmaceuticals Type and Applications
Table Bristol-Myers Squibb Cancer Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Cancer Biopharmaceuticals Type and Applications
Table AstraZeneca Cancer Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
Table Mylan Basic Information, Manufacturing Base and Competitors
Table Mylan Cancer Biopharmaceuticals Type and Applications
Table Mylan Cancer Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
Table LEO Pharma Basic Information, Manufacturing Base and Competitors
Table LEO Pharma Cancer Biopharmaceuticals Type and Applications
Table LEO Pharma Cancer Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
Table Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table Boehringer Ingelheim Cancer Biopharmaceuticals Type and Applications
Table Boehringer Ingelheim Cancer Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
Table Alexion Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Alexion Pharmaceuticals Cancer Biopharmaceuticals Type and Applications
Table Alexion Pharmaceuticals Cancer Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
Table Elusys Therapeutics Basic Information, Manufacturing Base and Competitors
Table Elusys Therapeutics Cancer Biopharmaceuticals Type and Applications
Table Elusys Therapeutics Cancer Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018)
Table Global Cancer Biopharmaceuticals Revenue (Million USD) by Players (2014-2019)
Table Global Cancer Biopharmaceuticals Revenue Share by Players (2014-2019)
Figure Global Cancer Biopharmaceuticals Revenue Share by Players in 2017
Figure Global Cancer Biopharmaceuticals Revenue Share by Players in 2018
Figure Global Top 5 Players Cancer Biopharmaceuticals Revenue Market Share in 2018
Figure Global Top 10 Players Cancer Biopharmaceuticals Revenue Market Share in 2018
Figure Global Cancer Biopharmaceuticals Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Cancer Biopharmaceuticals Revenue (Million USD) by Regions (2014-2019)
Table Global Cancer Biopharmaceuticals Revenue Market Share by Regions (2014-2019)
Figure Global Cancer Biopharmaceuticals Revenue Market Share by Regions (2014-2019)
Figure Global Cancer Biopharmaceuticals Revenue Market Share by Regions in 2018
Figure North America Cancer Biopharmaceuticals Revenue and Growth Rate (2014-2019)
Figure Europe Cancer Biopharmaceuticals Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Cancer Biopharmaceuticals Revenue and Growth Rate (2014-2019)
Figure South America Cancer Biopharmaceuticals Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Cancer Biopharmaceuticals Revenue and Growth Rate (2014-2019)
Table North America Cancer Biopharmaceuticals Revenue by Countries (2014-2019)
Table North America Cancer Biopharmaceuticals Revenue Market Share by Countries (2014-2019)
Figure North America Cancer Biopharmaceuticals Revenue Market Share by Countries (2014-2019)
Figure North America Cancer Biopharmaceuticals Revenue Market Share by Countries in 2018
Figure USA Cancer Biopharmaceuticals Revenue and Growth Rate (2014-2019)
Figure Canada Cancer Biopharmaceuticals Revenue and Growth Rate (2014-2019)
Figure Mexico Cancer Biopharmaceuticals Revenue and Growth Rate (2014-2019)
Table Europe Cancer Biopharmaceuticals Revenue (Million USD) by Countries (2014-2019)
Figure Europe Cancer Biopharmaceuticals Revenue Market Share by Countries (2014-2019)
Figure Europe Cancer Biopharmaceuticals Revenue Market Share by Countries in 2018
Figure Germany Cancer Biopharmaceuticals Revenue and Growth Rate (2014-2019)
Figure UK Cancer Biopharmaceuticals Revenue and Growth Rate (2014-2019)
Figure France Cancer Biopharmaceuticals Revenue and Growth Rate (2014-2019)
Figure Russia Cancer Biopharmaceuticals Revenue and Growth Rate (2014-2019)
Figure Italy Cancer Biopharmaceuticals Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Cancer Biopharmaceuticals Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Cancer Biopharmaceuticals Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Cancer Biopharmaceuticals Revenue Market Share by Countries in 2018
Figure China Cancer Biopharmaceuticals Revenue and Growth Rate (2014-2019)
Figure Japan Cancer Biopharmaceuticals Revenue and Growth Rate (2014-2019)
Figure Korea Cancer Biopharmaceuticals Revenue and Growth Rate (2014-2019)
Figure India Cancer Biopharmaceuticals Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Cancer Biopharmaceuticals Revenue and Growth Rate (2014-2019)
Table South America Cancer Biopharmaceuticals Revenue by Countries (2014-2019)
Table South America Cancer Biopharmaceuticals Revenue Market Share by Countries (2014-2019)
Figure South America Cancer Biopharmaceuticals Revenue Market Share by Countries (2014-2019)
Figure South America Cancer Biopharmaceuticals Revenue Market Share by Countries in 2018
Figure Brazil Cancer Biopharmaceuticals Revenue and Growth Rate (2014-2019)
Figure Argentina Cancer Biopharmaceuticals Revenue and Growth Rate (2014-2019)
Figure Colombia Cancer Biopharmaceuticals Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Cancer Biopharmaceuticals Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Cancer Biopharmaceuticals Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Cancer Biopharmaceuticals Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Cancer Biopharmaceuticals Revenue Market Share by Countries in 2018
Figure Saudi Arabia Cancer Biopharmaceuticals Revenue and Growth Rate (2014-2019)
Figure UAE Cancer Biopharmaceuticals Revenue and Growth Rate (2014-2019)
Figure Egypt Cancer Biopharmaceuticals Revenue and Growth Rate (2014-2019)
Figure Nigeria Cancer Biopharmaceuticals Revenue and Growth Rate (2014-2019)
Figure South Africa Cancer Biopharmaceuticals Revenue and Growth Rate (2014-2019)
Table Global Cancer Biopharmaceuticals Revenue (Million USD) by Type (2014-2019)
Table Global Cancer Biopharmaceuticals Revenue Share by Type (2014-2019)
Figure Global Cancer Biopharmaceuticals Revenue Share by Type (2014-2019)
Figure Global Cancer Biopharmaceuticals Revenue Share by Type in 2018
Table Global Cancer Biopharmaceuticals Revenue Forecast by Type (2019-2024)
Figure Global Cancer Biopharmaceuticals Market Share Forecast by Type (2019-2024)
Figure Global Biologics Revenue Growth Rate (2014-2019)
Figure Global Biosimilars Revenue Growth Rate (2014-2019)
Table Global Cancer Biopharmaceuticals Revenue by Application (2014-2019)
Table Global Cancer Biopharmaceuticals Revenue Share by Application (2014-2019)
Figure Global Cancer Biopharmaceuticals Revenue Share by Application (2014-2019)
Figure Global Cancer Biopharmaceuticals Revenue Share by Application in 2018
Table Global Cancer Biopharmaceuticals Revenue Forecast by Application (2019-2024)
Figure Global Cancer Biopharmaceuticals Market Share Forecast by Application (2019-2024)
Figure Global Liquid Cancers Revenue Growth Rate (2014-2019)
Figure Global Solid Cancers Revenue Growth Rate (2014-2019)
Figure Global Cancer Biopharmaceuticals Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Cancer Biopharmaceuticals Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Cancer Biopharmaceuticals Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Cancer Biopharmaceuticals Revenue Market Forecast (2019-2024)
Figure Europe Cancer Biopharmaceuticals Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Cancer Biopharmaceuticals Revenue Market Forecast (2019-2024)
Figure South America Cancer Biopharmaceuticals Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Cancer Biopharmaceuticals Revenue Market Forecast (2019-2024)
世界の転移性大腸がんの治療市場：市場規模・現状・予測 Colorectal cancer is the third most common type cancer and represents 9.7% of total cancer cases across the globe. According to American Cancer Society colorectal cancer is treatable and curable when it is localized to the bowel. However, colorectal cancer cancers that have spread to other body part…- 世界の転移性結腸直腸がん手術市場：市場規模・現状・予測 Colorectal cancer is the third most common type cancer and represents 9.7% of total cancer cases across the globe. According to American Cancer Society colorectal cancer is treatable and curable when it is localized to the bowel. However, colorectal cancer cancers that have spread to other body part…
- 世界の副鼻腔がんの治療市場：市場規模・現状・予測 If cancer is in the ethmoid sinus, treatment may include the following: Surgery followed by radiation therapy. A clinical trial of combination chemotherapy before surgery or radiation therapy. A clinical trial of combination chemotherapy after surgery or other cancer treatment.In 2018, the global Pa…
- 非腫瘍バイオ医薬品の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Biopharmaceutical, also known as a biologic (al) medical product, biological, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semi synthesized from biological sources. Different from totally synthesized pharmaceuticals, they include vaccines, blood, blood componen…
- RNA系バイオ医薬品市場：世界及び中国市場分析・予測（～2024年） RNA-based Biopharmaceuticals Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global RNA-based Biopharmaceuticals industry with a focus on the Chinese market. The report provides key statistics on the market status of the RNA-based Bi…